Acetylsalicylic acid Completed Phase 4 Trials for Acute Coronary Syndromes (ACS) / Ischemic Heart Disease Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00404781Effects of Optimized Antiplatelet Treatment After Percutaneous Coronary Intervention